Overview
- 10 inspections across 8 sites are on record.
- 9 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-21.
At a glance
Inspections
10
Sites
8
Observations
9
Career since
Nov 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Kedrion Biopharma Inc. | 21 May 2026 | Biologics | View 483 → |
| Kedrion S.p.A. | 10 Apr 2025 | Biologics | |
| Kedrion S.p.A. | 7 Apr 2025 | Biologics | On file |
| Baxalta Belgium Manufacturing SA | 22 Nov 2024 | Biologics | View 483 → |
| Sanofi Winthrop Industrie | 17 Nov 2023 | Biologics | On file |
Sites inspected
Kedrion Biopharma Inc.Melville, United States1 insp.
Kedrion S.p.A.Gallicano, Italy1 insp.
Kedrion S.p.A.Barga, Italy1 insp.
Baxalta Belgium Manufacturing SALessines, Belgium1 insp.
Sanofi Winthrop IndustrieLyon, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Lu Deng2 shared
Lisa T Pham2 shared
Erin C Hill2 shared
Roger F Zabinski2 shared
Olga Simakova2 shared
Scott T Ballard1 shared
Alan L Truong1 shared
Shafiq Ahadi1 shared
Xiuju Lu1 shared
Gregory A Price1 shared
Full investigator report
Get the verbatim findings behind Malgorzata G Norton's 9 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site